NUWE icon

Nuwellis

5.28 USD
+0.06
1.15%
At close Aug 25, 4:00 PM EDT
Pre-market
5.12
-0.16
3.03%
1 day
1.15%
5 days
-10.51%
1 month
-56.44%
3 months
-85.88%
6 months
-89.44%
Year to date
-89.52%
1 year
-91.21%
5 years
-100.00%
10 years
-100.00%
 

About: Nuwellis Inc is a medical technology company focused on developing, manufacturing, and commercializing a medical device used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems. The Aquadex Smartflow System removes excess fluid from patients suffering from fluid overload who have not responded to medical management, including diuretics. Nuwellis has one reportable segment: fluid overload.

Employees: 38

0
Funds holding %
of 7,429 funds
Analysts bullish %

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

150% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 2

4.32% more ownership

Funds ownership: 3.16% [Q1] → 7.48% (+4.32%) [Q2]

18% less funds holding

Funds holding: 11 [Q1] → 9 (-2) [Q2]

44% less capital invested

Capital invested by funds: $129K [Q1] → $72.1K (-$56.5K) [Q2]

50% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 4

Research analyst outlook

We haven’t received any recent analyst ratings for NUWE.

Financial journalist opinion

Based on 9 articles about NUWE published over the past 30 days

Neutral
GlobeNewsWire
4 days ago
Nuwellis Receives FDA 510(k) Clearance for New Dual Lumen Extended Length Catheter
MINNEAPOLIS, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company focused on fluid management, today announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for a new size of its Dual Lumen Extended Length Catheter (dELC).
Nuwellis Receives FDA 510(k) Clearance for New Dual Lumen Extended Length Catheter
Neutral
GlobeNewsWire
6 days ago
Nuwellis Signs Letter of Intent to Explore Acquisition of Rendiatech Ltd., A Real-Time Fluid Monitoring Company
Proposed acquisition supports strategy to drive technology expansion of fluid management offering to include continuous renal health monitoring technologies supporting the full patient journey, from early risk assessment to targeted fluid removal
Nuwellis Signs Letter of Intent to Explore Acquisition of Rendiatech Ltd., A Real-Time Fluid Monitoring Company
Neutral
GlobeNewsWire
1 week ago
Nuwellis, Inc. to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech
MINNEAPOLIS, Aug. 15, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company delivering fluid management solutions for critically ill patients, today announced that it will present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech being held virtually August 19-21, 2025. Details for the presentation are as follows: Date/Time: Thursday, August 21, 2025 at 2:40 PM ET Presenter: John Erb, President and Chief Executive Officer Registration Link: HERE About Webull Financial Webull Financial is a leading online brokerage platform committed to empowering self-directed investors with innovative tools and cutting-edge technology.
Nuwellis, Inc. to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech
Neutral
Seeking Alpha
1 week ago
Nuwellis, Inc. (NUWE) Q2 2025 Earnings Call Transcript
Nuwellis, Inc. (NASDAQ:NUWE ) Q2 2025 Earnings Conference Call August 14, 2025 9:00 AM ET Company Participants John L. Erb - CEO, President & Chairman of the Board Leah McMullen - Corporate Participant Robert B.
Nuwellis, Inc. (NUWE) Q2 2025 Earnings Call Transcript
Neutral
GlobeNewsWire
1 week ago
Nuwellis, Inc. Reports Second Quarter 2025 Financial Results and Business Highlights
MINNEAPOLIS, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a commercial-stage medical technology company dedicated to transforming care for fluid overload patients, today announced financial results for the second quarter ended June 30, 2025, and provided a business update.
Nuwellis, Inc. Reports Second Quarter 2025 Financial Results and Business Highlights
Neutral
GlobeNewsWire
2 weeks ago
Nuwellis to Exit International Operations to Accelerate U.S. Revenue Growth and Strategic Focus
MINNEAPOLIS, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company delivering fluid management solutions for critically ill patients, today announced its decision to exit international operations in order to focus exclusively on the U.S. market—where the company is seeing the strongest growth and clinical demand. This strategic realignment supports Nuwellis' core business strategy: investing in the markets driving revenue growth.
Nuwellis to Exit International Operations to Accelerate U.S. Revenue Growth and Strategic Focus
Neutral
GlobeNewsWire
2 weeks ago
Nuwellis Postpones Second Quarter 2025 Earnings Release and Conference Call to August 14, 2025
MINNEAPOLIS, Aug. 06, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company focused on fluid management, today announced that it will postpone its 2025 second quarter earnings release and conference call, originally scheduled for August 12, 2025. The Company requires additional time to complete its valuations and for its audit firm to complete its related audit procedures.
Nuwellis Postpones Second Quarter 2025 Earnings Release and Conference Call to August 14, 2025
Neutral
GlobeNewsWire
2 weeks ago
Nuwellis Announces the First Successful Outpatient Application of the Aquadex Smartflow® System Under New CMS Code
MINNEAPOLIS, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company dedicated to transforming fluid management, today announced that the first patients have been successfully treated with Aquadex® ultrafiltration therapy in a hospital-based outpatient setting. This milestone reflects a major advancement in the company's mission to improve access to fluid management and support better care across the continuum.
Nuwellis Announces the First Successful Outpatient Application of the Aquadex Smartflow® System Under New CMS Code
Neutral
GlobeNewsWire
3 weeks ago
Nuwellis Stockholders Approve All Proposals at Special Meeting
MINNEAPOLIS , Aug. 04, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company focused on fluid management, today announced that stockholders approved all proposals presented at the company's Special Meeting of Stockholders, held virtually earlier today. Each proposal was designed to enhance the company's financial flexibility and support ongoing strategic growth.
Nuwellis Stockholders Approve All Proposals at Special Meeting
Neutral
GlobeNewsWire
1 month ago
Nuwellis Participates in the Virtual Investor “What's Your Story” Summer Spotlight On-Demand Conference
MINNEAPOLIS, July 23, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc., today announced that John Erb, President and Chief Executive Officer of Nuwellis, participated in the Virtual Investor “What's Your Story” Summer Spotlight On-Demand Conference. For the event, Mr.
Nuwellis Participates in the Virtual Investor “What's Your Story” Summer Spotlight On-Demand Conference
Charts implemented using Lightweight Charts™